These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29091299)

  • 41. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
    Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
    Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
    Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
    Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease.
    Kim S; Park S; Kim B; Kwon J
    Sci Rep; 2016 Jun; 6():27849. PubMed ID: 27279075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
    Serviddio G; Bellanti F; Vendemiale G
    Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
    Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
    Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q; Sha S; Sun L; Zhang J; Dong M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity.
    Liu X; Wang K; Wang L; Kong L; Hou S; Wan Y; Ma C; Chen J; Xing X; Xing C; Jiang Q; Zhao Q; Cui B; Huang Z; Li P
    Hepatology; 2023 Aug; 78(2):562-577. PubMed ID: 35931467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet.
    Liu Z; Dou W; Ni Z; Wen Q; Zhang R; Qin M; Wang X; Tang H; Cao Y; Wang J; Zhao S
    Mol Med Rep; 2016 Aug; 14(2):1323-31. PubMed ID: 27315552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.
    Wang PX; Zhang XJ; Luo P; Jiang X; Zhang P; Guo J; Zhao GN; Zhu X; Zhang Y; Yang S; Li H
    Nat Commun; 2016 Feb; 7():10592. PubMed ID: 26882989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukocyte Ig-like receptor B4 (LILRB4) is a potent inhibitor of FcgammaRI-mediated monocyte activation via dephosphorylation of multiple kinases.
    Lu HK; Rentero C; Raftery MJ; Borges L; Bryant K; Tedla N
    J Biol Chem; 2009 Dec; 284(50):34839-48. PubMed ID: 19833736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance.
    Luo P; Wang PX; Li ZZ; Zhang XJ; Jiang X; Gong J; Qin JJ; Guo J; Zhu X; Yang S; Li H
    Am J Pathol; 2016 May; 186(5):1278-92. PubMed ID: 26976243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
    Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
    Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
    Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
    Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice.
    Nagata N; Xu L; Kohno S; Ushida Y; Aoki Y; Umeda R; Fuke N; Zhuge F; Ni Y; Nagashimada M; Takahashi C; Suganuma H; Kaneko S; Ota T
    Diabetes; 2017 May; 66(5):1222-1236. PubMed ID: 28209760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. JIP3 knockout protects mice against high fat diet-induced liver injury.
    Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
    Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Wehr A; Baeck C; Ulmer F; Gassler N; Hittatiya K; Luedde T; Neumann UP; Trautwein C; Tacke F
    PLoS One; 2014; 9(11):e112327. PubMed ID: 25372401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C-Jun/C7ORF41/NF-κB axis mediates hepatic inflammation and lipid accumulation in NAFLD.
    Yan FJ; Wang X; Wang SE; Hong HT; Lu J; Ye Q; Zheng YL; Wang YJ
    Biochem J; 2020 Feb; 477(3):691-708. PubMed ID: 31957809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.